|
Sign In to gain access to subscriptions and/or personal tools.
|
This version was published on September
1, 2005
Journal of Biomolecular Screening, Vol. 10, No. 6,
590-598 (2005)
DOI: 10.1177/1087057105275983
Peptide Binding Identifies an ER Conformation That Generates Selective Activity in Multiple In Vitro Assays
Christopher J. Larson
Departments of Molecular & Cell Biology and New Leads Discovery Ligand Pharmaceuticals, San Diego, CA
Deborah L. Osburn
Departments of Molecular & Cell Biology and New Leads Discovery Ligand Pharmaceuticals, San Diego, CA
Katherine Schmitz
Departments of Molecular & Cell Biology and New Leads Discovery Ligand Pharmaceuticals, San Diego, CA
Leslie Giampa
Departments of Molecular & Cell Biology and New Leads Discovery Ligand Pharmaceuticals, San Diego, CA
Shau-Ming Mong
Departments of Molecular & Cell Biology and New Leads Discovery Ligand Pharmaceuticals, San Diego, CA
Keith Marschke
Departments of Molecular & Cell Biology and New Leads Discovery Ligand Pharmaceuticals, San Diego, CA
H. Martin Seidel
Departments of Molecular & Cell Biology and New Leads Discovery Ligand Pharmaceuticals, San Diego, CA
Jonathan Rosen
Departments of Molecular & Cell Biology and New Leads Discovery Ligand Pharmaceuticals, San Diego, CA
Andrés Negro-Vilar
Departments of Molecular & Cell Biology and New Leads Discovery Ligand Pharmaceuticals, San Diego, CA
Drugs such as tamoxifen, which act at the estrogen receptor (ER), have very different in vitro and in vivo effects from those of the native hormone. Previous research has established that different ligands induce distinct conformational changes in the ER, thus affecting the interactions of the receptor with cell-specific coactivating or corepressing proteins (cofactors) and estrogen response elements (EREs), thus potentially driving differing biological effects. Affinity-selected peptides have been used to probe the conformational changes that occur within the ER upon binding various ligands. In this study, the authors characterize the ability of several peptides to be recruited to liganded ER under cellular conditions. Approximating ER conformation via recruitment of this peptide to the ER is concluded to be a better predictor of the agonist nature of an ER ligand under these different cellular contexts than is a canonical cotransfection transactivation assay.
Key Words: agonism Gal4 DNA-binding domain ligand-binding domain nuclear receptor selective estrogen receptor modulator

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Hall and D. P. McDonnell
Coregulators in Nuclear Estrogen Receptor Action: From Concept to Therapeutic Targeting
Mol. Interv.,
December 1, 2005;
5(6):
343 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|